General Biotechnology

Staffing needs seen in biotech industry A top Labor Department official said yesterday that community colleges nationwide could boost their […]

Getting Investors’ Pulses Beating Again Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004’s ‘promising products’

Getting Investors’ Pulses Beating Again Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004’s ‘promising products’

Financial Snapshot For October 2003 Stocks On New Plateau

Vatican steps in on biotech foods debate The Vatican stepped into the charged debate over genetically modified food on Monday,

A survey of strategic licensing practices in the pharmaceutical industry Alliances often appear to be a relatively cost-effective and rapid

The Generic Retribution The generic industry has always been overshadowed by branded pharmaceuticals. The government policies and the mandate have

October sees a frenzy of biotech IPOs October was the busiest month in three years for initial public offerings in

Venture Financing: Ready To Rebound? There’s little doubt that the financing window has opened up, but investors, analysts and biotech

Analyzing Brand-name and Generic Drug Costs in the U.S. and Eight Other Countries A new Wharton study comparing average prices